Novartis Ducks Regeneron's Antitrust Countersuit To IP Fight
A New York federal judge Monday tossed Regeneron Pharmaceuticals' antitrust lawsuit brought against rival Novartis Pharmaceuticals in response to Novartis' lawsuit claiming Regeneron infringed its patent related to a prefilled syringe...To view the full article, register now.
Already a subscriber? Click here to view full article